메뉴 건너뛰기




Volumn 25, Issue 2, 2018, Pages e113-e119

Neutrophil–lymphocyte ratio predicts response to chemotherapy in triple-negative breast cancer

Author keywords

Neoadjuvant chemotherapy; Neutrophil lymphocyte ratio; Pathologic complete response; Recurrence free survival; Triple negative breast cancer

Indexed keywords

C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P53; ANTINEOPLASTIC AGENT; TUMOR MARKER;

EID: 85046261068     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.25.3888     Document Type: Article
Times cited : (60)

References (47)
  • 1
    • 0035845511 scopus 로고    scopus 로고
    • Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
    • Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869–74.
    • (2001) Proc Natl Acad Sci U S A , vol.98 , pp. 10869-10874
    • Sorlie, T.1    Perou, C.M.2    Tibshirani, R.3
  • 2
    • 0042838307 scopus 로고    scopus 로고
    • Breast cancer classification and prognosis based on gene expression profiles from a population-based study
    • Sotiriou C, Neo SY, McShane LM, et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci U S A 2003;100:10393–8.
    • (2003) Proc Natl Acad Sci U S A , vol.100 , pp. 10393-10398
    • Sotiriou, C.1    Neo, S.Y.2    McShane, L.M.3
  • 3
    • 70349119837 scopus 로고    scopus 로고
    • Triple negative breast cancers: Clinical and prognostic implications
    • Dawson SJ, Provenzano E, Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur j Cancer 2009;45(suppl 1):27–40.
    • (2009) Eur J Cancer , vol.45 , pp. 27-40
    • Dawson, S.J.1    Provenzano, E.2    Caldas, C.3
  • 5
    • 0035751675 scopus 로고    scopus 로고
    • Preoperative chemotherapy in patients with operable breast cancer: Nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18
    • Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001;30:96–102.
    • (2001) J Natl Cancer Inst Monogr , vol.30 , pp. 96-102
    • Wolmark, N.1    Wang, J.2    Mamounas, E.3    Bryant, J.4    Fisher, B.5
  • 7
    • 17444454498 scopus 로고    scopus 로고
    • Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
    • Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483–93.
    • (1997) J Clin Oncol , vol.15 , pp. 2483-2493
    • Fisher, B.1    Brown, A.2    Mamounas, E.3
  • 8
    • 0035890633 scopus 로고    scopus 로고
    • Preoperative chemotherapy in primary operable breast cancer: Results from the European Organization for Research and Treatment of Cancer trial 10902
    • van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001;19:4224–37.
    • (2001) J Clin Oncol , vol.19 , pp. 4224-4237
    • Van Der Hage, J.A.1    Van De Velde, C.J.2    Julien, J.P.3    Tubiana-Hulin, M.4    Vandervelden, C.5    Duchateau, L.6
  • 9
    • 41649102048 scopus 로고    scopus 로고
    • Response to neoadjuvant therapy and long-term survival in patients with triplenegative breast cancer
    • Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triplenegative breast cancer. J Clin Oncol 2008;26:1275–81.
    • (2008) J Clin Oncol , vol.26 , pp. 1275-1281
    • Liedtke, C.1    Mazouni, C.2    Hess, K.R.3
  • 10
    • 77954576948 scopus 로고    scopus 로고
    • Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: Results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer
    • Colleoni M, Cole BF, Viale G, et al. Classical cyclophosphamide, methotrexate, and fluorouracil chemotherapy is more effective in triple-negative, node-negative breast cancer: results from two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. J Clin Oncol 2010;28:2966–73.
    • (2010) J Clin Oncol , vol.28 , pp. 2966-2973
    • Colleoni, M.1    Cole, B.F.2    Viale, G.3
  • 11
    • 84949976531 scopus 로고    scopus 로고
    • Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
    • Prat A, Fan C, Fernandez A, et al. Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy. BMC Med 2015;13:303.
    • (2015) BMC Med , vol.13 , pp. 303
    • Prat, A.1    Fan, C.2    Fernandez, A.3
  • 12
    • 84862303759 scopus 로고    scopus 로고
    • Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes
    • von Minckwitz G, Untch M, Blohmer JU, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol 2012;30:1796–804.
    • (2012) J Clin Oncol , vol.30 , pp. 1796-1804
    • Von Minckwitz, G.1    Untch, M.2    Blohmer, J.U.3
  • 13
    • 0034931803 scopus 로고    scopus 로고
    • Activated human neutrophils release hepatocyte growth factor/scatter factor
    • McCourt M, Wang JH, Sookhai S, Redmond HP. Activated human neutrophils release hepatocyte growth factor/scatter factor. Eur J Surg Oncol 2001;27:396–403.
    • (2001) Eur J Surg Oncol , vol.27 , pp. 396-403
    • McCourt, M.1    Wang, J.H.2    Sookhai, S.3    Redmond, H.P.4
  • 14
    • 79956329617 scopus 로고    scopus 로고
    • Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer
    • Mahmoud SM, Paish EC, Powe DG, et al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J Clin Oncol 2011;29:1949–55.
    • (2011) J Clin Oncol , vol.29 , pp. 1949-1955
    • Mahmoud, S.M.1    Paish, E.C.2    Powe, D.G.3
  • 15
    • 84925498897 scopus 로고    scopus 로고
    • High neutrophil-tolymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer
    • Rossi L, Santoni M, Crabb SJ, et al. High neutrophil-tolymphocyte ratio persistent during first-line chemotherapy predicts poor clinical outcome in patients with advanced urothelial cancer. Ann Surg Oncol 2015;22:1377–84.
    • (2015) Ann Surg Oncol , vol.22 , pp. 1377-1384
    • Rossi, L.1    Santoni, M.2    Crabb, S.J.3
  • 16
    • 84905164478 scopus 로고    scopus 로고
    • Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: A systematic review and meta-analysis
    • dju124
    • Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst 2014;106:dju124.
    • (2014) J Natl Cancer Inst , pp. 106
    • Templeton, A.J.1    McNamara, M.G.2    Seruga, B.3
  • 17
    • 84856679198 scopus 로고    scopus 로고
    • Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients
    • Azab B, Bhatt VR, Phookan J, et al. Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 2012;19:217–24.
    • (2012) Ann Surg Oncol , vol.19 , pp. 217-224
    • Azab, B.1    Bhatt, V.R.2    Phookan, J.3
  • 18
    • 84934441600 scopus 로고    scopus 로고
    • Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer
    • Koh CH, Bhoo-Pathy N, Ng KL, et al. Utility of pre-treatment neutrophil–lymphocyte ratio and platelet–lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 2015;113:150–8.
    • (2015) Br J Cancer , vol.113 , pp. 150-158
    • Koh, C.H.1    Bhoo-Pathy, N.2    Ng, K.L.3
  • 19
    • 84876095247 scopus 로고    scopus 로고
    • Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients
    • Noh H, Eomm M, Han A. Usefulness of pretreatment neutrophil to lymphocyte ratio in predicting disease-specific survival in breast cancer patients. J Breast Cancer 2013;16:55–9.
    • (2013) J Breast Cancer , vol.16 , pp. 55-59
    • Noh, H.1    Eomm, M.2    Han, A.3
  • 20
    • 84856670885 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response
    • Fisher CS, Ma CX, Gillanders WE, et al. Neoadjuvant chemotherapy is associated with improved survival compared with adjuvant chemotherapy in patients with triple-negative breast cancer only after complete pathologic response. Ann Surg Oncol 2012;19:253–8.
    • (2012) Ann Surg Oncol , vol.19 , pp. 253-258
    • Fisher, C.S.1    Ma, C.X.2    Gillanders, W.E.3
  • 21
    • 33847063053 scopus 로고    scopus 로고
    • The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes
    • Carey LA, Dees EC, Sawyer L, et al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res 2007;13:2329–34.
    • (2007) Clin Cancer Res , vol.13 , pp. 2329-2334
    • Carey, L.A.1    Dees, E.C.2    Sawyer, L.3
  • 22
    • 84888633713 scopus 로고    scopus 로고
    • Inf lammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
    • Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inf lammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013;13:759–71.
    • (2013) Nat Rev Cancer , vol.13 , pp. 759-771
    • Elinav, E.1    Nowarski, R.2    Thaiss, C.A.3    Hu, B.4    Jin, C.5    Flavell, R.A.6
  • 23
    • 41549114264 scopus 로고    scopus 로고
    • A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer
    • Chanrion M, Negre V, Fontaine H, et al. A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer. Clin Cancer Res 2008;14:1744–52.
    • (2008) Clin Cancer Res , vol.14 , pp. 1744-1752
    • Chanrion, M.1    Negre, V.2    Fontaine, H.3
  • 24
    • 84933181457 scopus 로고    scopus 로고
    • Role of inflammatory infiltrates in triple negative breast cancer
    • Matsumoto H, Koo SL, Dent R, Tan PH, Iqbal J. Role of inflammatory infiltrates in triple negative breast cancer. J Clin Pathol 2015;68:506–10.
    • (2015) J Clin Pathol , vol.68 , pp. 506-510
    • Matsumoto, H.1    Koo, S.L.2    Dent, R.3    Tan, P.H.4    Iqbal, J.5
  • 25
    • 84907210556 scopus 로고    scopus 로고
    • Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer
    • Loi S. Host antitumor immunity plays a role in the survival of patients with newly diagnosed triple-negative breast cancer. J Clin Oncol 2014;32:2935–7.
    • (2014) J Clin Oncol , vol.32 , pp. 2935-2937
    • Loi, S.1
  • 26
    • 84868093750 scopus 로고    scopus 로고
    • Nsaid analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup
    • Retsky M, Rogers R, Demicheli R, et al. nsaid analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res Treat 2012;134:881–8.
    • (2012) Breast Cancer Res Treat , vol.134 , pp. 881-888
    • Retsky, M.1    Rogers, R.2    Demicheli, R.3
  • 27
    • 84865191854 scopus 로고    scopus 로고
    • Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    • Ono M, Tsuda H, Shimizu C, et al. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer. Breast Cancer Res Treat 2012;132:793–805.
    • (2012) Breast Cancer Res Treat , vol.132 , pp. 793-805
    • Ono, M.1    Tsuda, H.2    Shimizu, C.3
  • 29
    • 43049133286 scopus 로고    scopus 로고
    • The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
    • Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology 2007;73:215–20.
    • (2007) Oncology , vol.73 , pp. 215-220
    • Yamanaka, T.1    Matsumoto, S.2    Teramukai, S.3    Ishiwata, R.4    Nagai, Y.5    Fukushima, M.6
  • 30
    • 84880314861 scopus 로고    scopus 로고
    • Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer
    • Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 2012;29:3092–100.
    • (2012) Med Oncol , vol.29 , pp. 3092-3100
    • Wang, D.S.1    Luo, H.Y.2    Qiu, M.Z.3
  • 31
    • 24344442821 scopus 로고    scopus 로고
    • Neutrophil– lymphocyte ratio as a prognostic factor in colorectal cancer
    • Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil– lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–4.
    • (2005) J Surg Oncol , vol.91 , pp. 181-184
    • Walsh, S.R.1    Cook, E.J.2    Goulder, F.3    Justin, T.A.4    Keeling, N.J.5
  • 32
    • 84929158217 scopus 로고    scopus 로고
    • Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients
    • Pistelli M, De Lisa M, Ballatore Z, et al. Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients. BMC Cancer 2015;15:195.
    • (2015) BMC Cancer , vol.15 , pp. 195
    • Pistelli, M.1    De Lisa, M.2    Ballatore, Z.3
  • 33
    • 84944909050 scopus 로고    scopus 로고
    • Elevated preoperative neutrophilto- lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer
    • Hong J, Mao Y, Chen X, et al. Elevated preoperative neutrophilto- lymphocyte ratio predicts poor disease-free survival in Chinese women with breast cancer. Tumour Biol 2016;37:4135–42.
    • (2016) Tumour Biol , vol.37 , pp. 4135-4142
    • Hong, J.1    Mao, Y.2    Chen, X.3
  • 34
    • 0037180757 scopus 로고    scopus 로고
    • Inflammation and cancer
    • Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–7.
    • (2002) Nature , vol.420 , pp. 860-867
    • Coussens, L.M.1    Werb, Z.2
  • 35
    • 40349094954 scopus 로고    scopus 로고
    • Inflammation and breast cancer. Balancing immune response: Crosstalk between adaptive and innate immune cells during breast cancer progression
    • DeNardo DG, Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res 2007;9:212.
    • (2007) Breast Cancer Res , vol.9 , pp. 212
    • Denardo, D.G.1    Coussens, L.M.2
  • 36
    • 79954657385 scopus 로고    scopus 로고
    • Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
    • Kuang DM, Zhao Q, Wu Y, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 2011;54:948–55.
    • (2011) J Hepatol , vol.54 , pp. 948-955
    • Kuang, D.M.1    Zhao, Q.2    Wu, Y.3
  • 37
    • 0023637126 scopus 로고
    • Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha–induced changes in circulating numbers of neutrophils and lymphocytes
    • Ulich TR, del Castillo J, Keys M, Granger GA, Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha–induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 1987;139:3406–15.
    • (1987) J Immunol , vol.139 , pp. 3406-3415
    • Ulich, T.R.1    Del Castillo, J.2    Keys, M.3    Granger, G.A.4    Ni, R.X.5
  • 38
    • 67649304466 scopus 로고    scopus 로고
    • Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03
    • Teramukai S, Kitano T, Kishida Y, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer 2009;45:1950–8.
    • (2009) Eur J Cancer , vol.45 , pp. 1950-1958
    • Teramukai, S.1    Kitano, T.2    Kishida, Y.3
  • 39
    • 0023231451 scopus 로고
    • Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system
    • El-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol 1987;139:2406–13.
    • (1987) J Immunol , vol.139 , pp. 2406-2413
    • El-Hag, A.1    Clark, R.A.2
  • 40
    • 79955809907 scopus 로고    scopus 로고
    • Exocytosis of azurophil and arginase 1–containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation
    • Rotondo R, Bertolotto M, Barisione G, et al. Exocytosis of azurophil and arginase 1–containing granules by activated polymorphonuclear neutrophils is required to inhibit T lymphocyte proliferation. J Leukoc Biol 2011;89:721–7.
    • (2011) J Leukoc Biol , vol.89 , pp. 721-727
    • Rotondo, R.1    Bertolotto, M.2    Barisione, G.3
  • 41
    • 0035953308 scopus 로고    scopus 로고
    • Ifngamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
    • Shankaran V, Ikeda H, Bruce AT, et al. ifngamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001;410:1107–11.
    • (2001) Nature , vol.410 , pp. 1107-1111
    • Shankaran, V.1    Ikeda, H.2    Bruce, A.T.3
  • 42
    • 84874371112 scopus 로고    scopus 로고
    • Preoperative neutrophil to lymphocyte ratio > 5 is a prognostic factor for recurrent colorectal cancer
    • Mallappa S, Sinha A, Gupta S, Chadwick SJ. Preoperative neutrophil to lymphocyte ratio > 5 is a prognostic factor for recurrent colorectal cancer. Colorectal Dis 2013;15:323–8.
    • (2013) Colorectal Dis , vol.15 , pp. 323-328
    • Mallappa, S.1    Sinha, A.2    Gupta, S.3    Chadwick, S.J.4
  • 43
    • 84945544960 scopus 로고    scopus 로고
    • Predictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer
    • Asano Y, Kashiwagi S, Onoda N, et al. Predictive value of neutrophil/lymphocyte ratio for efficacy of preoperative chemotherapy in triple-negative breast cancer. Ann Surg Oncol 2016;23:1104–10.
    • (2016) Ann Surg Oncol , vol.23 , pp. 1104-1110
    • Asano, Y.1    Kashiwagi, S.2    Onoda, N.3
  • 44
    • 0021330196 scopus 로고
    • Normal values for peripheral blood white cell counts in women of four different ethnic origins
    • Bain B, Seed M, Godsland I. Normal values for peripheral blood white cell counts in women of four different ethnic origins. J Clin Pathol 1984;37:188–93.
    • (1984) J Clin Pathol , vol.37 , pp. 188-193
    • Bain, B.1    Seed, M.2    Godsland, I.3
  • 45
    • 84903549095 scopus 로고    scopus 로고
    • Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer
    • Cihan YB, Arslan A, Cetindag MF, Mutlu H. Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev 2014;15:4225–31.
    • (2014) Asian Pac J Cancer Prev , vol.15 , pp. 4225-4231
    • Cihan, Y.B.1    Arslan, A.2    Cetindag, M.F.3    Mutlu, H.4
  • 46
    • 84952665646 scopus 로고    scopus 로고
    • Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy
    • Suppan C, Bjelic-Radisic V, La Garde M, et al. Neutrophil/lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer 2015;15:1027.
    • (2015) BMC Cancer , vol.15 , pp. 1027
    • Suppan, C.1    Bjelic-Radisic, V.2    La Garde, M.3
  • 47
    • 84945475726 scopus 로고    scopus 로고
    • Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
    • Restivo A, Cocco IM, Casula G, et al. Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer. Br J Cancer 2015;113:1133–9.
    • (2015) Br J Cancer , vol.113 , pp. 1133-1139
    • Restivo, A.1    Cocco, I.M.2    Casula, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.